Changes in ctDNA levels after MIBG therapy in patients with relapsed or refractory neuroblastoma.

10012Background: Circulating tumor DNA (ctDNA) is detectable in children with neuroblastoma. Less is known about how levels change during treatment and the implications of these changes. We evaluat...